Welcome to our dedicated page for Ayr Wellness news (Ticker: AYRWF), a resource for investors and traders seeking the latest updates and insights on Ayr Wellness stock.
AYR Wellness Inc. (AYRWF) is a vertically integrated cannabis operator with multi-state retail dispensaries and proprietary cannabis products. This page serves as the definitive source for official company announcements and market-relevant developments.
Investors and industry observers will find curated press releases covering regulatory milestones, earnings reports, and retail expansions. Our aggregation ensures efficient tracking of operational updates across AYR's cultivation, manufacturing, and distribution networks.
Content spans licensing achievements, product portfolio enhancements, and compliance initiatives critical to understanding this cannabis operator's positioning. Bookmark this resource for streamlined monitoring of AYR's progress in evolving markets.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has announced the filing of its unaudited interim financial statements and Management's Discussion and Analysis (MD&A) for Q1 2025. The documents are now available on SEDAR+ and SEC's EDGAR system.
The company provided definitions of non-GAAP measures used in their reporting, including "Adjusted EBITDA" and "Adjusted Gross Profit". These metrics are used to evaluate business performance and capital structure, offering investors additional perspectives on operational decision-making.
AYR Wellness (OTCQX: AYRWF) has executed a definitive senior secured bridge term loan agreement providing up to $50 million in committed funding. The Bridge Facility, secured through CSAC Holdings Inc., will support ongoing operations and facilitate business transition under the July 30, 2025 restructuring support agreement (RSA).
The facility includes multiple draws with 14% per annum interest rate payable in kind, featuring Initial Term Loans (Tranche A and B) and Delayed Draw Term Loans. Key premiums include 10% commitment premium, 10% exit premium, and 15% backstop premium. The facility requires maintaining minimum liquidity of $17.5 million and will automatically convert into a senior secured "take-back" term facility upon completion of the planned Article 9 sale transaction.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has entered into a Restructuring Support Agreement (RSA) with senior noteholders to restructure its debt and transition ownership. The agreement includes:
The deal features a $50 million Bridge Facility at 14% interest rate, an Article 9 sale process for assets in six states (Florida, Ohio, Nevada, New Jersey, Pennsylvania, and Virginia), and conversion of senior notes into 100% equity in the new company (NewCo). The restructuring involves asset sales, debt restructuring, and potential liquidation of remaining assets through Companies' Creditors Arrangement Act proceedings.
Senior noteholders will receive pro-rata shares of NewCo equity in exchange for canceling credit bid portion of notes, while remaining note balances will be entitled to proceeds from remaining asset liquidation.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has secured an additional extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 29, 2025.
The waiver covers defaults related to delayed Q1 2025 financial statements and certain payment defaults under other outstanding debt. While temporary, this agreement prevents noteholders from exercising default-related rights during the waiver period. The company continues normal operations while evaluating growth opportunities in key markets.
AYR Wellness (OTCQX: AYRWF) has secured an additional extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 25, 2025. The extension maintains the temporary waiver of certain defaults related to delayed Q1 2025 financial filings and potential payment defaults on other outstanding debt.
This agreement prevents senior noteholders from exercising default-related rights while providing AYR additional time to negotiate with senior lenders and explore strategic options to strengthen its capital structure. The company continues to operate normally while evaluating growth opportunities in key markets.
AYR Wellness (OTCQX: AYRWF) has secured an extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 18, 2025. The waiver addresses defaults related to delayed Q1 2025 financial filings and certain payment defaults on outstanding debt.
The temporary waiver prevents noteholders from exercising default-related rights while the company continues negotiations with senior lenders and explores strategic options to strengthen its capital structure. AYR continues to operate normally and evaluate growth opportunities while working with stakeholders to address its financial obligations.
AYR Wellness (OTCQX: AYRWF) has received a Notification of Disposition of Collateral from Anthony J. DePaul regarding potential reclamation and sale of its interest in PA Natural Medicine LLC, which operates three medical cannabis dispensaries in Pennsylvania. The notice cites alleged defaults under the Pledge Agreement.
Additionally, the company has secured a Second Amendment to its Limited Waiver Agreement with senior noteholders, extending the temporary waiver period to July 11, 2025. This extension relates to defaults from delayed Q1 2025 financial filings and certain payment defaults, providing AYR additional time for negotiations with senior lenders and exploration of capital structure alternatives.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, announced it has missed its June 30, 2025 interest payment on its outstanding senior notes. If the payment is not made by July 30, 2025, it will trigger an event of default.
The company's Interim CEO Scott Davido stated this is a strategic step in their ongoing debt restructuring efforts. AYR is currently in discussions with majority noteholders regarding capital structure alternatives as part of a broader strategic review announced on May 30, 2025. The company maintains that the missed interest payment is not expected to impact its operational capabilities.
AYR Wellness (OTCQX: AYRWF), a vertically integrated U.S. multi-state cannabis operator, announced delays in filing its Q1 2025 interim financial statements and related documents. The delay is attributed to ongoing negotiations with creditors and assessment of debt obligation classifications with senior lenders.
The company is currently under a failure-to-file cease-trade order (FFCTO) issued by the Ontario Securities Commission, which prohibits trading of AYR's securities in Canadian jurisdictions and has resulted in a trading suspension on the Canadian Securities Exchange. AYR is conducting a broader strategic review to address upcoming payment obligations and support its long-term strategic plan.
FAQ
What is the current stock price of Ayr Wellness (AYRWF)?
What is the market cap of Ayr Wellness (AYRWF)?
